Skip to content

Clinical trials

Observational Hemorrhage trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemorrhage Phase: Observational Country / region: Belgium Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20121
20131
20142
20181
20223

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Unknown status2
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ArtVentive Medical Group, Inc.1
AstraZeneca1
Baki Topal1
Brugmann University Hospital1
Erasme University Hospital1
R&D Cardiologie1
Universitaire Ziekenhuizen KU Leuven1
University Hospital, Ghent1
University Hospital, Grenoble1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemorrhage9
Gastrointestinal Hemorrhage3
Atrial Fibrillation2
Emergencies2
Thrombosis2
Acute Coronary Syndrome1
Arteriovenous Fistula1
Arteriovenous Malformations1
Blood Coagulation Disorders1
Cardiovascular Diseases1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.